Imaging and technologies for prostate cancer. Where are we now-where do we go?
MetadataShow full item record
Citationde la Rosette, J. J. M. C. H., Sanchez Salas, R., Rastinehad, A. ve Polascik, T. J. (2021). Imaging and technologies for prostate cancer. Where are we now-where do we go? World Journal of Urology, 39(3), 635-636. https://dx.doi.org/10.1007/s00345-021-03641-5
We have been witnessing rapid advances in the diagnosis and treatment of prostate cancer. While some approaches have matured, others are still in their infancy. We have learned that Active Surveillance is safe in patients with lowrisk prostate cancer while patients with high-risk prostate cancer are best served by a multimodality approach including surgery, radiotherapy, and medical management [1, 2]. In patients with moderate-risk prostate cancer, we are balancing our choice between cancer control and cancer cure. While surgery ofers a potential cure for the disease, it also harbors a signifcant probability for morbidity and complications. Hence many men and their partners value not to impair quality of life as a possible trade-of for a defnitive cure.